Authors
Latest:
Nonventilator Hospital-Acquired Pneumonia: Epidemiology, Prevention, and Where It Is NowThe management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.
Latest:
Advancing STOP2030 Treatment in Global HealthAlejandro Krolewiecki, MD discusses the path to regulatory approval, collaboration with global health organizations, and the role of partnerships in scaling up the new treatment for neglected tropical diseases.
Latest:
The Impact of Widespread RSV Vaccination and Quantifying ResultsIn the fourth and final episode, the clinicians speak of the need for greater uptake of the RSV vaccines, overcoming an "RSV identity crisis," and the potential ancillary benefit of reducing bacterial infections.
Latest:
Fluoroquinolone Safe for Treating Severe Refractory M Pneumoniae PneumoniaInvestigators asked the children’s parents about the history of musculoskeletal-related disease, observed the children’s gait, and performed physical examinations.
Latest:
Navigating the Challenges of CMS AUR Reporting Mandates: Penalties, Progress, and PitfallsThe long-term benefits of antimicrobial use and resistance (AUR) reporting is about improving patient care and combating resistance.
Latest:
Examining the HIV Treatment PipelineA review of selected investigational long-active treatment options for HIV.
Latest:
Does Slow Viral Clearance and Viral Rebound During Infection Contribute to Long COVID?Annie Antar, MD, PhD, offers insights around her research on her findings on this subject.
Latest:
Do Antibiotic Adverse Effects Affect Prescribing Practices?A focus group study reviewed provider practices to learn more about patient management and explore the potential to follow up with clinicians on important takeaways.
Latest:
Improving the Diagnosis of Intracardiac InfectionsThis technology is effective in cases that are difficult to diagnose.
Latest:
Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant FoeSalmonella becomes more dangerous as antimicrobial resistance grows. Read about its most common manifestations.
Latest:
Lessons in Resilience: What HIV Teaches Us About COVID-19Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
Latest:
Final Diagnosis: Donor-Derived Staphylococcus Iugdunensis Endocarditis of Transplanted Heart"This case gives uncomfortable insight into a gap in early detection of infections in immunocompromised, high-risk patient populations. "
Latest:
Cefiderocol’s Role in Managing Carbapenem-Resistant Acinetobacter baumannii InfectionsThis agent is likely best utilized as part of a combination when treating this bacterium but data regarding appropriate combinations are scarce.
Latest:
Pulmonary Coinfection With C neoformans and C immitis: A Novel Fungal CohabitationA patient presented with a history of uncontrolled HIV and a history of polysubstance use.
Latest:
Need for Speed: Rapid Antiretroviral Initiation in the Emergency DepartmentEmergency departments (EDs) are an important entry point into the health care system and have been identified as a location with opportunity for increased HIV diagnosis and management.
Latest:
Improving Screening, Management of Hepatitis C in Infants and ChildrenDespite hepatitis C (HCV) incidence rates increasing, adequate screening for the virus continues to be a pressing challenge for public health officials.
Latest:
Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation InfectionsThere has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.
Latest:
Antimicrobial Stewardship Can Help Prevent Injection Drug Use–Related InfectionsEscalating usage and more drug choices are putting more people at risk.
Latest:
World Polio Day: A Time to Reflect on Accomplishments, Acknowledge There’s Still Work to DoCarol Pandak, EdD, director of PolioPlus, Rotary International, discusses the significance of this day and efforts that continue around the world to work towards eradication of this disease.
Latest:
A Day Late and a Dollar Short: Managing Antimicrobial Drug ShortagesWith antimicrobial drug shortages expected to continue globally, developing mitigation strategies is essential to prevent complications, including antimicrobial resistance.
Latest:
Detecting T Cell Dysfunction in Post-Acute Infection SyndromesNigel McCracken, PhD, presents a diagnostic test to identify early T cell dysfunction in syndromes like Long COVID and ME/CFS, aiming to improve treatment strategies before symptoms escalate.
Latest:
Exploring the Recently Approved and Upcoming Clostridioides difficile TherapeuticsThis market has seen a flurry of activity, as shown by a review of the latest agents.
Latest:
The Challenges of Hepatitis B Clinical Care Within Underserved CommunitiesIn the second part of their interview, Debika Bhattacharya, MD MSc, and Su H. Wang, MD, MPH, FACP, continue the conversation around the difficulties of getting people into care, and what the new hepatitis B guidelines hope to improve in this area.
Latest:
2024 S aureus and MRSA Trials: Key TakeawaysJeffrey Freiberg, MD, PhD review of the SABATO trial on oral antibiotics for S aureus bacteremia and a comparison of mupirocin and iodine treatments for MRSA decolonization.
Latest:
Assisting With International Health Care NeedsAlthough the pandemic halted many medical mission assignments, these opportunities and others are becoming available to help those geographic areas with acute needs.
Latest:
Should Cefazolin be Prescribed in Patients With B-lactam Allergies?For patients undergoing surgery, looking at the potential benefits of this antimicrobial for prophylaxis.
Latest:
National Youth HIV/AIDS Awareness Day Reminds Young People They Are Not ForgottenDuring these uncertain times, RAIN President and CEO Chelsea Gulden talks about the importance of taking a grassroots approach to HIV advocacy to work with young people in the local communities who are either dealing with the virus or are susceptible to it.
Latest:
IMUNON’s IMNN-101 Vaccine Shows Promising Results in Phase 1 Trial, Demonstrates Cross-Reactivity Against COVID VariantsStacy Lindborg, PhD, highlights the vaccine’s immune response, safety, and global distribution potential.
